| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |